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INTRODUCTION AND HISTORY 
 
Two American surgeons, named Halsted and Hall, had ﬁrst 
injected cocaine at the peripheral sites near ulnar, musculocutaneous, 
supratrochlear and infratrochlear nerve and produced nerve block for 
minor surgical procedures in 1880. Then, James Leonard Corning used 
Esmarch bandage in 1885 with peripheral nerve block and had tried to 
prolong the duration of action of local anaesthetic agent by arresting the 
circulation and reducing the absorption of it from the tissues. This idea 
was further advanced by Braun using epinephrine mixed with LA agent 
as chemical tourniquet in 1903. 
At the beginning of civilization, though the surgeons were the 
pioneer, regarding the early discoveries of regional anaesthesia but the 
developing speciality of anaesthesiology had gradually dominated over it. 
So, after that the role of regional anaesthesia or peripheral nerve block 
has expanded from the operating room to the arena of postoperative 
recovery and pain management clinic by holding the hand of anaesthetist. 
Previously, the peripheral nerve block was applied only on the adult and 
selected group of patients. But later it was proved that with the 
appropriate selection of patients and with the help of sedation the regional 
techniques of peripheral nerve block can also be used for all the age 
group of patients. There are different techniques of RA for extremities. 
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But, the duration of surgery inﬂ uences both the type of regional 
technique selected and the choice of local anaesthetic agent used.  
The plans for postoperative pain relief also inﬂuence the approach 
to the peripheral nerve block or techniques of RA.  Any anaesthesiologist 
does not under estimate the role of sedation during surgery under RA or 
peripheral nerve block. For example, many perfect brachial plexus block 
has been undone due to the inadequate management of sedation. Regional 
blockade on the extremities or peripheral nerve block has wide 
application by not only providing the surgical anaesthesia and analgesia, 
but as well as treating the chronic pain syndromes involving the 
extremities. RA on extremity (upper or lower) or others regional 
anaesthesia on trunk, including sympathetic ganglion blockade, have also 
several other advantages during the posto perative period, compared with 
general anaesthesia. These include: decreased requirement of sedation, 
decreased nausea and vomiting, minimum stay in hospital, early 
discharge and a smooth transition from parenteral to oral analgesic or 
other drugs as the block or anaesthetic effects dissipate gradually. During 
peripheral nerve block continuous infusion of local anaesthetic agents 
near a peripheral plexus of nerve via a percutaneous catheter has also 
become an increasingly common form of regional anaesthesia, if surgery 
is prolonged or post operative analgesia is needed 
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AIM OF THE STUDY 
 
This study was conducted to test the hypothesis that an injection in 
USG guided Interscalene block a few millimetres  lateral to the brachial 
plexus sheath reduces the incidence of hemidiaphragmatic paresis as 
compared  to conventional intrafascial injection,  yet  providing similar 
analgesia 
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NERVE SUPPLY OF UPPER LIMB 
The brachial plexus provides the complete motor and nearly the 
total sensory innervation to the upper limb. It is formed by the anterior 
primary rami (or ventral rami) of C5, C6, C7, C8 and T1 spinal nerve 
with variable contribution from the anterior primary rami of C4 and or T2 
spinal nerve. These anterior primary rami (or ventral rami) are called the 
roots of brachial plexus. The after exit from their respective intervertebral 
foramen, these spinal nerves ﬁ rst cross the transverse process of 
corresponding cervical vertebra at the same level and lie between the 
anterior and middle scalene muscle. The anterior scalene muscle arises 
from the ant.tubercle of transverse process of seven cervical vertebrae 
(C1 to C7) and take insertion on the scalene tubercle of ﬁ rst rib in front 
of the subclavian artery. The middle scalene muscle also arises from the 
posterior tubercle of the transverse process of seven cervical vertebra(C1 
to C7) and takes insertion on the 1st rib behind the subclavian artery. The 
prevertebral fascia which arises from the anterior and posterior tubercle 
of the transverse processes of seven cervical vertebrae, after ﬁrst 
investing both the scalene, fuse laterally and enclose the brachial plexus 
in a fascial sheath. This is called the brachial plexus sheath. Thus, the 
brachial plexus sheath is continuous from its origin at the level of seven 
transverse processes of cervical vertebrae in the neck to its distal insertion 
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at the level of the origin of coracobrachialis muscle. Hydrostatically this 
brachial plexus sheath is intact throughout its course. So, ﬁlling of this 
sheath with LA agent at various levels is the basis of brachial plexus 
block for conducting different type of regional anaesthesia (RA) of upper 
extrimity. As the roots of the brachial plexus emerge through the groove 
between the anterior and posterior tubercles of the transverse process of 
the seven cervical vertebrae, therefore it also emerges through the groove 
between the scalene anterior and scalene medius muscle, because they 
take origin from the anterior and posterior tubercles respectively. So, they 
lie in a ﬁbrofatty tissue space which is situated between the two sheaths 
of ﬁbrous tissue (brachial plexus sheath) investing these two muscles. 
Laterally, this sheath also extends into the axilla as a coveing membrane 
around the brachial plexus as it emerges into the axilla.  
Between the scalene muscles (anterior and middle) the nerve roots 
of the brachial plexus, i.e anterior primary rami of C5-8 and T1 spinal 
nerve unite and ﬁrst form the three trunks of brachial plexus. There they 
lie cephaloposterior to the subclavian artery as it courses along the upper 
surface of the ﬁrst rib. The superior trunk is formed by the union of the 
anterior primary rami of C5, C6 and sometimes C4 nerve root. The 
middle trunk is formed by the anterior primary rami of the C7 nerve root 
alone. The inferior trunk is formed by the anterior primary rami of the C8 
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and T1 nerve root and sometimes from T2 nerve root. After their 
formation these three trunks of brachial plexus converge towards the apex 
of axilla to meet the anatomical needs of neck, which requires 
hypermobility in all directions. This convergence of nerve trunks is 
maximally tightest just medial to the ﬁrst rib, which is about 4 cm lateral 
to the tranverse processes of C6 vertebra. At this point, the brachial 
plexus assumes its most compact arrangements and block of it at this 
level cause rapid and complete surgical anaesthesia and analgesia of the 
upper limb. The trunks of brachial plexus in the neck lie in the posterior 
triangle and is also invested by the sheath of prevertebral fascia. In the 
posterior triangle the trunks of brachial plexus are superﬁcially placed 
and covered only by skin, platysma and deep fascia. In such position they 
are also crossed by a number of structures such as the inferior belly of 
omohyoid, external jugular vein, transverse cervical artery and 
supraclavicular nerves. Within the posterior triangle of neck, in a thin 
subject, the trunks of brachial plexus can also easily be palpated by the 
ﬁngers. The upper and middle trunks of brachial plexus lie above the 
subclavian artery as the artery crosses the 1st rib. But the lower tunk lies 
behind the artery and it may make a groove on the rib immediately 
posterior to the subclavian artery. At the lateral border of 1st rib, each 
trunk of brachial plexus divides into anterior and   posterior divisions that  
passes posterior to the middle 1/3 of the clavicle. Then, the different 
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combinations of  joining of the anterior and posterior division of the three 
trunks form the cords of brachial plexus just when they enter into the 
axilla. Within the axilla these cords are named as lateral, posterior and 
medial according to their relationship with the 2nd part of the axillary 
artery which is situated within the same brachial sheath. The superior (or 
anterior) divisions of the superior and middle trunk joins to form the 
lateral cord. The inferior (or posterior) divisions from all these trunks join 
to form the posterior cord. The anterior division of inferior trunk 
continues as medial cord. Within the axilla at the lateral border of 
pectoralis minor muscle these cords again divide into peripheral nerves 
supplying the upper extremity 
Among the peripheral nerves of upper extremity, the 
musculocutaneous nerve which arises from the lateral cord of brachial 
plexus is the most proximal branch. So, the proximity of this nerve 
explains why it is the most commonly spared nerve during the axillary 
approach of brachial plexus block. The next highest or proximal branch 
of the brachial plexus, after musculocutaneous nerve, is the axillary nerve 
and it arises from the posterior cord. Its position also explains why 
surgical procedures, requiring wide spread total upper extrimity motor 
block are conducted most often by the technique or approach which is 
more proximal than the axillary approach of the brachial plexus block. 
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After the axillary nerve, the median nerve arises from the lateral and 
medial cord. The radial nerve arises from the posterior cord and the ulnar 
nerve arises from the medial cord respectively. 
 Besides the terminal branches or peripheral nerves which arise 
from the cords, several branches also arise from the roots of brachial 
plexus providing motor innervation to the rhomboid muscle (C5), 
subclavian muscle (C5, C6), serratus anterior muscle (C5, C6, C7), etc. 
Suprascapular nerve arises from the C5, C6 nerve root and supply the 
muscles of the doral aspect of scapula and sensory to the shoulder joint. 
So, to block these nerves higher approaches for brachial plexus block 
such as the interscalene approach is necessary. 
 For brachial plexus block four sites or approaches for injection of 
local anaesthetic agents are chosen such as: interscalene, supraclavicular, 
infraclavicular and axillary. The indications, results, technique and 
complications of brachial plexus block are speciﬁc for each site or 
approach. The site should be selected according to the surgical 
requirement, potential complication and anaesthesiologist’s ability or 
skill. The proximal branches of brachial plaxus arising from the roots at 
cervical region are usually blocked only by the interscalene approach of 
brachial plexus block. The axillary approach of brachial plexus block 
takes places at the site of origin of the terminal branches of the plexus. At 
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this level the terminal branches have a constant relationship to the 
axillary artery. For example the median nerve is lateral to the artery, the 
ulnar nerve is medial to the artery and the radial nerve is posterior to the 
artery. This constant relationship of these nerves helps in easy 
identiﬁcation and complete block of these nerves through axillary route 
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The composition of the brachial plexus can be summarized as follows 
Brachial plexus is formed from the ventral rami of C5–8 and T1. 
Occasionally, there may be a significant contribution from C4  (prefixed) 
or from T2 (post-fixed). The following arrangement is usually seen: 
1. Roots – five roots emerge from the intervertebral foramina and 
continue between the scalenus medius and scalenus anterior. Here the 
roots  unite as follows into: 
2. Trunks:    
Upper – from C5 and C6  
Middle – continues from C7                       
Lower – from C8 and T1 
3. Divisions – each trunk divides into an anterior and  posterior 
division behind the clavicle. These divisions continue on into the axilla 
and form into Cords – according to their position around the auxiliary                          
 Lateral – anterior divisions of   upper and middle trunks 
 Medial – anterior division of lower trunk 
 Posterior – posterior divisions of all three trunks  
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The  important larger branches of the brachial plexus are: 
1. Supraclavicular branches: 
 Dorsal scapular nerve (C5) – to the rhomboids 
 Long thoracic nerve (C5–7) – to the serratus anterior 
 Small branches to scalenus/longus colli muscles 
 Suprascapular nerve (C5, 6) – to the scapular area 
 Nerve to subclavius (C5, 6) – to the subclavius 
2. Infraclavicular branches: 
Lateral cord: 
 Lateral pectoral nerve (C5–7) – to the pectoralis major and   minor 
 Musculocutaneous nerve (C5–7) – to the biceps, brachialis and 
skin (via the lateral cutaneous nerve of the forearm) 
Medial cord: 
 Medial pectoral nerve (C8–T1) – to the pectoralis minor 
 Medial cutaneous nerve of the arm (C8–T1) 
 Medial cutaneous nerve of the forearm (C8–T1) 
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Posterior cord: 
 Upper subscapular nerve (C5, 6) – to the subscapularis 
 Lower subscapular nerve (C5,6) – to the subscapularis and teres 
major 
 Thoracodorsal nerve (C5–7) – to the latissimus dorsi 
 Axillary nerve (C5, 6) – to the deltoid 
 Radial nerve (C5–T1) – formed from the posterior cord 
 Median nerve (C6–T1) – formed from the medial and lateral cords 
 Ulnar nerve (C8, T1) – formed from C8, T1) – formed from the 
medial cord 
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This figure shows distribution of brachial plexus 
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VARIOUS BLOCK TECHNIQUES 
Field Block Technique 
A field block  is a local anesthetic injection that targets terminal 
cutaneous nerves . Field blocks are used commonly by surgeons to 
minimize incisional pain and may be used as a supplementary technique 
or as a sole anesthetic for minor, superficial procedures. 
Anesthesiologists often use field blocks to anesthetize the superficial 
cervical plexus for procedures involving the neck or shoulder; the 
intercostobrachial nerve for surgery involving the medial upper extremity 
proximal to the elbow (in combination with a brachial plexus nerve 
block); and the saphenous nerve for surgery involving the medial leg or 
ankle joint (in combination with a sciatic nerve block). Field blocks may 
be undesirable in cases where they obscure the operative anatomy, or 
where local tissue acidosis from infection prevents eff ective local 
anesthetic functioning. 
Paresthesia Technique 
 Formerly the mainstay of regional anesthesia, this technique is 
now rarely used for nerve localization. Using known anatomic 
relationships and surface landmarks as a guide, a block needle is placed 
in proximity to the target nerve or plexus. When a needle makes direct 
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contact with a sensory nerve, a paresthesia (abnormal sensation) is 
elicited in its area of sensory distribution.   
  Nerve Stimulation Technique   
For this technique, an insulated needle concentrates electrical 
current at the needle tip, while a wire attached to the needle hub connects 
to a nerve  stimulator—a battery-powered machine that emits a small 
amount (0–5 mA) of electric current at a set interval (usually 1 or 2 Hz). 
A grounding electrode is attached to the patient to complete the circuit. 
When the insulated needle is placed inproximity to a motor nerve, muscle 
contractions are induced, and local anesthetic is injected. Although it is 
common to redirect the block needle until muscle contractions occur at a 
current less than 0.5 mA, there is scant evidence to support this specific 
current in all cases. Similarly, although some have suggested that muscle 
contraction with current less than 0.2 mA implies intraneural needle 
placement, there is little evidence to support this specific cut off . 
Nonetheless, most practitioners inject local anesthetic when current 
between 0.2 and 0.5 mA results in a muscle response. For most blocks 
using thistechnique, 30–40 mL of anesthetic is usually injected with 
gentle aspiration between divided doses 
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Ultrasound Technique 
  Ultrasound for peripheral nerve localization is becoming 
increasingly popular; it may be used alone or combined with other 
modalities such as nerve stimulation. Ultrasound uses high-frequency (1–
20 MHz) sound waves emitted from piezoelectric crystals that travel at 
different rates through tissues of different densities, returning a signal to 
the transducer. Depending on the amplitude of signal received, the 
crystals deform to create an electronic voltage that is converted into a 
two-dimensional grayscale image . The degree of efficiency with which 
sound passes through a substance determines its echogenicity. Structures 
and substances through which sound passes easily are described as  
hypoechoic  and appear dark or black on the ultrasound screen. In 
contrast, structures refl ecting more sound waves appear brighter—or 
white—on the ultrasound screen, and are termed  hyperechoic .  Th e 
optimal transducer varies depending upon the depth of the target nerve 
and approach angle of the needle relative to the transducer . High-
frequency transducers provide a high-resolution picture with a relatively 
clear image butoff er poor tissue penetration and are therefore used 
predominantly for more superficial nerves. Lowfrequency transducers 
provide an image of poorer quality but have better tissue penetration and 
are therefore used for deeper structures. Transducers with a linear array 
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off er an undistorted image and are therefore oft en the first choice among 
practitioners. However, for deeper target nerves that require a more acute 
angle between the needle and long-axis of the transducer, a curved array 
(curvilinear) transducer will maximize returning ultrasound waves, 
providing the optimal needle image . Nerves are best imaged in cross-
section, where they have a characteristic honeycomb appearance (“short 
axis”). Needle insertion can pass either parallel (“in plane”) or not 
parallel (“out of plane”) to the plane of the ultrasound waves . Unlike 
nerve stimulation alone, ultrasound guidance allows for a variable volume 
of local anesthetic to be injected, with the fi nal amount determined by 
what is observed under direct vision. This technique usually results in a 
far lower injected volume of local anesthetic (10-30mL).    
A Linear probe offers higher resolution with less penetration. A 
Curvilinear probe provides better penetration with lower resolution 
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This figure shows in-plane and out-of-plane ultrasound approaches 
Continuous Peripheral Nerve Blocks  
Also termed perineural local anesthetic infusion , continuous 
peripheral nerve blocks involve the placement of a percutaneous catheter 
adjacent to a peripheral nerve, followed by local anesthetic administration 
to prolong a nerve block. Potential advantages appear to depend on 
successfully improving analgesia and include reductions in resting and 
dynamic pain, supplemental analgesic requirements, opioid-related side 
eff ects, and sleep disturbances. In some cases patient satisfaction, 
ambulation, and functioning may be improved; an accelerated resumption 
of passive joint range-of-motion realized; and reduced time until 
discharge-readiness as well as actual discharge from the hospital or 
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rehabilitation center achieved. There are many types of catheters, 
including nonstimulating and stimulating, flexible and more rigid, 
through-the-needle and over-the-n eedle. Currently, there is little 
evidence that a single design results in superior effects. Local anesthetic 
is the primary medication infused, as adjuvants do not add benefi ts to 
perineural infusions (unlike single-injection peripheral nerve blocks). 
Longacting local anesthetics (eg, ropivacaine) are more commonly used 
as they provide a more favorable  sensory-to-motor block ratio 
(optimizing analgesia while minimizing motor block). In an attempt to 
further minimize any induced motor block, dilute local anesthetic (0.1–
0.2%) is often infused; however, recent evidence suggests that it is the 
total dose, and not concentration, that determines the majority of block 
effects. Unlike  single -injection peripheral nerve blocks, no adjuvant 
added to a perineural local anesthetic  infusion  has been demonstrated to 
be of benefit. The local anesthetic may be administered exclusively as 
repeated bolus doses or a basal infusion, or as a combination of the two 
methods. Using a small, portable infusion pump, continuous peripheral 
nerve blocks may be provided on an ambulatory basis. As with all 
medical procedures, there are potential risks associated with continuous 
peripheral nerve blocks. Therefore, these infusions are usually reserved 
for patients having procedures expected to result in postoperative pain 
that is diffi cult to control with oral analgesics and will not resolve in less 
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time than the duration of a singleinjection peripheral nerve block. Serious 
complications, which are relatively rare, include systemic local anesthetic 
toxicity, catheter retention, nerve injury, infection, and retroperitoneal 
hematomaformation. In addition, a perineural infusion affecting the 
femoral nerve increases the risk of falling, although to what degree and 
by what specific mechanism (eg, sensory, motor, or proprioception 
deficits) remain unknown 
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INTERSCALENE APPROACH 
Interscalene block gives the most complete block for shoulder 
surgery and facilitates the placement of a catheter that can be used to 
extend the operative anesthesia or to administer prolonged postoperative 
analgesia if this is desired.  
PATIENT PREPARATION 
Patient Selection 
In general, patients scheduled for upper extremity surgery are  
considered candidates for Interscalene block. This can be used as the only 
anesthetic, as a supplement to provide analgesia and muscle relaxation 
along with general anesthesia, or as the initial step for provision of 
prolonged postoperative analgesia. Adamant refusal of regional 
anesthesia by a patient is a contraindication to the procedure. However, 
patient refusal is frequently a “relative” refusal. If the patient's real 
objections are to “being awake” or “being aware,” this can be managed 
by the use of sedatives and amnestic drugs. Other contraindications 
include local infection and severe systemic coagulopathy. The presence 
of preexisting neurologic disease is often discussed. Some data are 
available in the case of spinal anesthesia, but the use of peripheral nerve 
blockade in this situation is unclear. Although some physicians avoid any 
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procedure that may confuse the picture of postoperative neuropathy, 
others believe that if there is a clear difference in the potential injury and 
the preexisting disease, regional techniques are appropriate. There are no 
clear answers in this regard, and full patient education and cooperation 
are most appropriate. Finally, the level of patient anxiety is an important 
consideration. Extreme apprehension regarding surgery necessitates 
heavy sedation, and the advantages of regional anesthesia in providing 
rapid recovery, alertness, and protection of airway reflexes may be 
negated. The use of regional anesthesia in these situations is a matter of 
judgment and experience.  
Premedication and Sedation 
  The best preparation for a regional technique is careful patient 
education. Supplemental medication is also useful. In addition to the 
general comments about premedication discussed in earlier chapters, 
regional anesthesia techniques have special requirements. First, sedation 
must be adjusted to the required level of patient cooperation. With either 
the elicitation of a paresthesia or electrical stimulation technique, 
medication must be light enough to allow the patient to identify and 
report nerve contact. Although a mild dose of opioid (50 to 100 µg of 
fentanyl or equivalent) will help ease the discomfort of nerve localization, 
patient responsiveness must be maintained. This does not preclude the 
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use of an amnestic agent. Small doses of propofol or midazolam may 
provide excellent amnesia at levels of consciousness that still allow 
cooperation. 
 
This figure shows technique of interscalene brachial plexus 
block. 
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ULTRASOUND GUIDED INTERSCALENE BLOCK 
  For interscalene block by ultrasonographic guidance, either an in-
plane or out-of-plane approach can be used, depending on the experience 
and preference of the operator. For an in-plane approach, the needle is 
inserted in a posterolateral to anteromedial direction along the long axis 
of a high-frequency linear array transducer with the needle shaft and tip 
visualized. The middle and anterior scalene muscles should be visualized, 
and the hypoechoic nerve roots are usually stacked in a somewhat 
cephalocaudad arrangement. Injection should be made so that real-time 
spread of anesthetic can be visualized within the brachial plexus sheath 
spreading the crosssectional nerve roots apart. For an out-of-plane 
approach , the high-frequency linear array transducer may be placed just 
caudal to the conventional interscalene block injection point and just 
above the clavicle. The longitudinal axis of the transducer is oriented in a 
posterolateral to anteromedial direction, with the center of the probe 
overlying the interscalene space and the image of the nerve roots, which 
again will be hypoechoic in cross-section. The needle is introduced in a 
slightly dorsal, medial, and caudal direction, as originally described in the 
conventional technique by Winnie. Nerve stimulation can be used to 
confirm position of the needle tip in the brachial plexus 
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This figure shows USG picture of interscalene approach of brachial 
plexus block. 
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ADVANTAGES AND DISADVANTAGES 
Advantages of interscalene block include a superficial location of 
the interscalene space that makes it easily accessible by paresthesia, nerve 
stimulation, or ultrasonographic guidance techniques. Injection of an 
adequate volume of local anesthetic at the interscalene level results in 
reliably complete anesthesia or analgesia for surgery on or about the 
shoulder, including proximal humeral surgery. A single injection results 
in success rates approaching 100%. A catheter can be easily placed at this 
site. Finally, the axillary nerve to the deltoid and the musculocutaneous 
nerve to the biceps brachialis derive from the CS-C6 nerve roots, and 
therefore reliable relaxation of the deltoid and biceps muscles is 
guaranteed. This allows optimal surgical exposure and facilitates 
dislocation of the humeral head from the glenoid socket. If performed 
properly, it is impossible to cause a pneumothorax with an appropriate 
needle using this approach. 
Disadvantages include the lack of blood vessels in the interscalene 
space that make perivascular techniques impossible. Close proximity of 
the phrenic nerve, or perhaps nerve root marginalization of those fibers 
contributing to phrenic nerve formation, has rarely resulted in injury to 
these structures and reported cases of permanent phrenic nerve palsy. 
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Interscalene block with a volume of local anesthetic adequate for surgery 
results in 100% incidence of ipsilateral hemidiaphragmatic paresis 
In a landmark publication, Benumof reported four cases of 
permanent injury to the cervical spinal cord resulting from interscalene 
block performed during general anesthesia. Imaging of the cervical spinal 
cord showed vacuolization of the cord or the presence of a syrinx. 
Intraneural injection of local anesthetic under pressure has been found to 
spread along the longitudinal axis along the nerve during experimental 
studies. Thus, theoretically, injection into a proximal nerve root can 
spread and disrupt the cervical spinal cord. Performance of interscalene 
block in the anesthetized patient does not allow the patient to report 
painful paresthesia or other sensations. Sudden severe pain on injection 
during peripheral nerve block is a time-honored signal that neural tissue 
is endangered and that the needle should be promptly withdrawn and re-
sited. It hasbeen shown that needle contact with the nerve is often not 
associated with the ability to elicit a motor response during electrical 
stimulation. Reports of accidental intraneural injection during 
ultrasonographic needle guidance have been published. Therefore, no 
available modality can ensure against this devastating complication. It is 
strongly advised that interscalene block not be performed in a patient who 
is heavily sedated or following induction of general anesthesia 
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COMPLICATIONS 
RESPIRATORY COMPLICATIONS 
Ipsilateral hemidiaphragmatic paresis is a consistent side effect 
associated with interscalene block. It occurs with an incidence of 100%. 
This expected side effect takes on added importance if the patient has 
respiratory comorbidities, including contralateral phrenic or 
diaphragmatic pathology, severe chronic obstructive cardiopulmonary 
disease, neuromuscular disorders in which a 25% reduction in FVC 
would not be tolerated, or conditions that restrict ribcage motion such as 
ankylosing spondylitis. If these conditions are present, significant 
atelectasis or respiratory failure can occur. With proper technique and 
needle size, there is no possibility of causing a pneumothorax. 
Introduction of a catheter, nevertheless, could theoretically reach the apex 
of the lung 
Pulmonary function (such as FVC and forced expiratory volume in 
1 second) reductions of 25% to 30% occur routinely. These changes are 
usually complete within 15 minutes of completion of the injection. 
Increased upper rib cage expansion and ipsilateral paradoxical inward 
motion of the hemiabdomen have been reported. The combined effect of 
these changes is a reduced ability to cough and clear secretions, which 
may be poorly tolerated by a patient with severe COPD.  
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Hemidiaphragmatic paresis occurs 100% of the time with 
interscalene block and cannot be avoided by reducing the volume of local 
anesthetic injected. Volumes as low as 5 ML (which is inadequate for 
surgical anesthesia) have been associated with a 45% incidence of 
hemidiaphragmatic paresis. Similarly, reductions in local anesthetic 
concentration do not avoid this side effect, with concentrations of 
bupivacaine as low as 0.125% being associated with 100% incidence of 
hemidiaphragmatic paresis. The use of ultrasound-guided supraclavicular 
blocks may reduce the incidence of hemidiaphragmatic paresis from 
100%, but will still be expected to be associated with a significant 
incidence. Blocks above the clavicle are associated with spread of local 
anesthetic into the cervical plexus. The mechanism for phrenic nerve 
paresis is motor blockade of the C3-C5 nerve roots before forming the 
phrenic nerve. The main nerve root contributing to formation to the 
phrenic nerve is the C4 nerve root. Any block causing sensory blockade 
of C5, C4, or C3 would be expected to have associated phrenic paresis. A 
recent publication suggests that with careful deposition of local anesthetic 
by ultrasonographic guidance, the incidence of hemidiaphragmatic 
paresis may indeed be avoided during supraclavicular block.  
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LOCAL ANAESTHESIA 
Local anaesthetics are analgesic drugs that suppress action 
potentials by blocking voltage-activated sodium ion (Na+) channels in 
excitable tissues. Examples include the anaesthetic amides (e.g.  
lidocaine, bupivacaine, ropivacaine) and esters (e.g.  cocaine and 
procaine) . Other drugs which can inhibit voltageactivated Na+ channels, 
such as diphenhydramine (a first-generation histamine H1 receptor 
antagonist) and amitriptyline (a tricyclic antidepressant) also have local 
anaesthetic properties. The blockade of voltageactivated Na+ channels 
accounts for both their analgesic effects, mediated through inhibition of 
action potentials in nociceptive neurones, and their systemic effects. The 
inhibition of action potentials in the heart contributes to local anaesthetic 
toxicity and also accounts for the antiarrhythmic actions of intravenous 
lidocaine (a class 1b antiarrhythmic). Unlike general anaesthetics, local 
anaesthetics do not diminish consciousness when administered correctly. 
 Local anaesthetics block sensation at the site of administration by 
inhibiting action potentials in all nociceptive fibres and therefore do not  
discriminate between pain modalities, unlike other analgesic drugs, such 
as the anti-inflammatory agents and opioids. Opioid analgesics 
(morphine, fentanyl, hydrocodone, etc.) and other central  analgesic drugs 
such as the α2-adrenergic agents  (clonidine,  dexmedetomidine) activate 
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metabotropic (G  protein-coupled) receptors within the membranes of 
specific neurones located within the pain pathway. A component of the 
actions of these drugs is centrally mediated  
MECHANISM OF ACTION OF LOCAL ANAESTHETICS 
The primary target of local anaesthetics, the voltage- activated Na+ 
channel (VASC) is one of numerous membrane proteins which reside in 
the phospholipid bilayers encapsulating neurons. VASCs provide 
selective permeability to Na+ when the cell becomes depolarized from 
the resting potential (approximately −70 mV), which is maintained in 
quiescent neurones by the tonic activity of potassium ion (K+) channels. 
Local anaesthetics applied either topically to the skin or by infiltration 
inhibit action  potentials in primary afferent nociceptive neurones, the  
pain-sensing neurones which transmit to the dorsal horn of the spinal 
cord. Pain transmission begins as a depolarization in the nerve ending of 
the primary afferent neuron  initiated by the activation of cation channels. 
When the depolarization reaches the threshold for activation of VASCs 
(approximately −45 mV), action potentials are generated, resulting in 
rapid depolarization to approximately +20 mV. Each action potential is 
brief (approximately 2 ms) because VASCs rapidly inactivate, leading to 
closure of their inactivation gates, and at the same time voltage-activated 
K+ channels activate, leading to an increase in the permeability of the cell 
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membrane to K+. As a result,the membrane potential travels rapidly back 
towards the K+ equilibrium potential and this period is known as the 
after-hyperpolarization, a phenomenon which contributes to the refractory 
period during which it is unlikely that another action potential will be 
generated.  
Mechanism of Local Anaesthetic Inhibition of the Voltage-
Activated Na+ Channel Local anaesthetics inhibit VASC activity by 
gaining access to the open channel from the inside of the cell and binding 
to specific amino acids lining the channel lumen. They bind preferentially 
to the open channel and are therefore said to be use-dependent (or open 
channel) blockers. First, the local anaesthetic must cross the cell 
membrane, a passage which requires lipid solubility. The molecule must 
then diffuse into the aqueous environment within the ion channel. Amide 
and ester local anaesthetics posses both lipophilic and hydrophilic 
properties and are described as amphipathic. They exist in basic 
(uncharged) and cationic (charged) forms and the relative proportion of 
each (determined using the Henderson–Hasselbalch equation) is 
dependent upon the pH of the solution and the pKa of the local 
anaesthetic: 
pKa= pH log [CationicLA] / [UnchargedLA] 
log[CationicLA]/ [UnchargedLA]=pKa-pH 
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Local anaesthetics are weak bases and most have a pKa of 
approximately 8.5.  
Therefore thereapproximately 10-fold more charged than 
uncharged molecule at physiological pH (~7.5):  
log[Cationic LA ] / [Uncharged LA] =1  
                            log[Cationic LA ] / [Uncharged LA] = 10 
An alkaline solution speeds the onset of analgesia by increasing the 
proportion of uncharged local anaesthetic on the outside of the nerve, 
resulting in more rapid access to the inside of the cell where the balance 
of isoforms re-establishes on the basis of the intracellular pH. By 
contrast, infected and inflamed tissue has a relatively low (acidic) pH 
leading to an increase in the proportion of the membrane-impermeant 
cationic local anaesthetic component and the requirement for higher 
doses to achieve analgesia. 
THE VOLTAGE-ACTIVATED Na+ CHANNEL  
Local anaesthetics gain access to their binding site within the inner 
lumen of the VASC when the activation gate opens in response to 
depolarization. The VASC is formed by a large protein (the α-subunit) 
consisting of 24 membrane-spanning segments arranged in four repetitive 
motifs .The fourth segment of each motif is a voltage sensor, a series of 
positively charged amino acids (arginine and lysine residues) lying within 
the membrane. Depolarization causes electrostatic repulsion of the 
voltage sensors, providing the energy required to open the activation gate. 
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Na+ ions, selected by the filter formed by the four pore loops (between 
the 5th and 6th segments) lining the outer vestibule of the channel, are 
then free to pass down their  concentration gradient into the cell, 
generating a depolarizing electrical current. However, Na+ current is 
inhibited by local anaesthetic bound within the inner vestibule of the 
channel. The inactivation gate, formed by intracellular components of the 
channel, closes rapidly following depolarization and local anaesthetics 
stabilize the inactivated state. There are multiple subtypes of VASCs, 
named after the identity of their α-subunit encoded by one of nine 
different genes which are differentially expressed in tissues throughout 
the body and which have differing pharmacological and biophysical 
properties. This heterogeneity provides the potential for selectively 
targeting VASCs in pain-sensing neurones. Nociceptive neurones 
predominantly express NaV1.7, NaV1.8 and/or NaV1.9 α-subunits. 
Mutations in the SCN9A gene, which encodes NaV1.7, are associated 
with several pain pathologies. Aspects of systemic toxicity relate to the 
ability of local anaesthetics to block VASCs outside the pain pathway. 
Cardiac VASCs are of the NaV1.5 subtype and local anaesthetics such as 
ropivacaine and levobupivacaine are thought to have less systemic 
toxicity due to their lower affinity for cardiac channels. Additional VASC 
heterogeneity is conferred by four genes which encode ancillary β-
subunits. 
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LOCAL ANAESTHETIC STRUCTURE 
Local anaesthetics of the amide and ester classes share three 
structural moieties: an aromatic portion, an intermediate chain and an 
amine group. The aromatic portion is lipophilic, and lipid solubility is 
further enhanced in local anaesthetics with lengthy intermediate chains. 
The amine group is a proton acceptor, providing the potential for both 
charged and uncharged isoforms (i.e. the source of the amphipathic nature 
of local anaesthetics). Amide and ester anaesthetics are so named because 
of their distinctive bonds within the intermediate chain. Examples of 
esters are cocaine, procaine, chloroprocaine and amethocaine; examples 
of amides are lidocaine, prilocaine, mepivacaine, etidocaine, bupivacaine, 
ropivacaine and levobupivacaine. A convenient mnemonic is that the 
names of esters contain one letter i while those of amides contain two 
letters i’s. The presence of either an amide or an ester bond dictates the 
pathway through which the local anaesthetic is metabolized and this has 
important implications regarding allergy potential and pharmacokinetic 
profile (described below). Since the introduction of cocaine into clinical 
practice by Koller in 1884, numerous local anaesthetics have been 
synthesized, beginning with procaine in 1905. Structural modifications 
influence pharmacokinetics. For example, replacement of the tertiary 
amine by a piperidine ring increased local anaesthetic lipid solubility and 
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duration of action; addition of an ethyl group to lidocaine on the α-carbon 
of the  amide link created etidocaine; and addition of a  propyl group or  
butyl group to the amine end of mepivacaine resulted in [p]ropivacaine 
and bupivacaine respectively. Halogenation of the aromatic ring of 
procaine created chloroprocaine, an ester with faster hydrolysis and 
shorter duration of action. 
 
PHARMACOLOGICAL PROPERTIES OF LOCAL 
ANAESTHETICS 
  A number of important factors influence the pharmacological 
profile of local anaesthetic drugs. The pKa, molecular weight, lipid 
solubility, protein binding and vasoactivity influence speed of onset, 
potency and duration of action. 
   pKa is the pH at which the ionized and nonionized form of a 
compound is present in equal amounts. For basic drugs such as local 
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anaesthetics, the greater the pKa, the greater the ionized fraction. As 
diffusion across the nerve sheath and nerve membrane requires non-
ionized drug, a local anaesthetic with a low pKa has a fast onset of action 
while a high pKa causes a slow onset of action. For example, lidocaine 
(pKa 7.6) has a fast onset in comparison with bupivacaine (pKa 8.2), 
because, at pH 7.4, 35% of lidocaine exists in the non-ionized base form 
compared to only 20% of bupivacaine.  
 Molecular weight influences the rate of transfer of drug across 
nerve membranes and through the dura mater. The lower the molecular 
weight the more rapid is the transfer. 
   Lipid solubility, often expressed as the  partition coefficient, 
influences potency. The partition coefficient is the ratio of aqueous and 
lipid concentrations when a local anaesthetic is introduced into a mixture 
of oil- and water-based solvents. 
  Protein binding, including local anaesthetic attachment to protein 
components of the nerve membrane, increases the duration of action of a 
local anaesthetic. In plasma, amide anaesthetics bind predominantly to α-
acid glycoprotein (AAG), a high-affinity limited capacity protein, and 
albumin, a low-affinity large capacity protein. The bioavailability of 
anaesthetic is determined by the availability of plasma proteins; the 
greater the AAG availability, the greater the concentration. After surgery, 
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trauma or malignancy, AAG concentrations increase significantly and 
protect patients receiving local anaesthetic epidural or perineural 
infusions from anaesthetic toxicity by curbing increases in the free 
fraction of local anaesthetics.  
Vasoactivity influences potency and duration of action. The 
vasoactivity of commonly used local anaesthetics is biphasic with 
dilatation occurring with anaesthetic concentrations ≥0.25% and 
vasoconstriction at concentrations <0.25%. When measured by Laser 
Doppler flowmetry in the forearm, the vasoactive potencies occur in the 
order: lidocaine > bupivacaine > levobupivacaine > ropivacaine. 
Adrenaline at a dose of 1.25 μg provides significant vasoconstriction 
when administered with bupivacaine and levobupivacaine. 
DIFFERENTIAL SENSORY AND MOTOR BLOCKADE 
Local anaesthetics provide differential sensory and motor block 
dependent on fibre size. For example epidural administration of 0.5% 
bupivacaine provides excellent motor block for Caesarean section, yet 
administration of 0.1% bupivacaine, often with fentanyl 2 μg ml−1, can 
provide analgesia during labour but with full lowerlimb movement 
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This figure shows Ascending pain pathway 
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PHARMACOKINETICS 
 Absorption 
  The site, dose and rate of injection, and pharmacological 
properties, with or without addition of adrenaline, determine the 
absorption of a local anaesthetic drug from its site of injection. The rank 
order of plasma concentration after injection at various sites is: 
intrapleural > intercostal > lumbar epidural > brachial plexus > sciatic > 
femoral, which reflects the vascular supply to these tissues. Firstpass 
pulmonary metabolism limits the concentration of local anaesthetic which 
reaches the systemic circulation. 
Distribution  
Tissue distribution of local anaesthetics is proportional to the lipid 
solubility of the drug and the blood supply. Local anaesthetic drugs are 
distributed rapidly to brain, heart, liver and lungs but more slowly to 
muscle and fat, which have a lower blood supply. The patient’s age, 
cardiovascular status and hepatic function influence tissue blood flow. 
Metabolism Amide metabolism is dependent on hepatic blood flow. 
Toxicity of amides is more likely with prolonged infusions in sick, 
elderly patients, although thepostoperative increase in AAG attenuates 
the rise in plasma concentrations. Esters are hydrolysed rapidly in plasma 
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by pseudocholinesterase to the metabolite para-aminobenzoic acid 
(PABA), which can generate an allergic reaction. Amides are not 
metabolized to PABA and so allergic reactions are very rare.  
Clearance 
Clearance of amide local anaesthetics is dependent on hepatic 
metabolism, and metabolites may accumulate in renal failure. Metabolism 
is fastest in the rank order: prilocaine > lidocaine > bupivacaine. 
Placental Transfer Protein binding determines the rate and degree of 
diffusion of local anaesthetics across the placenta. The relative 
concentration of bupivacaine between umbilical vein and maternal 
circulation is 0.3, but fetal toxicity is dependent primarily on the free 
fraction of local anaesthetic, which is the same in mother and fetus. 
CLINICAL PREPARATION OF LOCAL 
ANAESTHETICS 
Local anaesthetics are presented clinically as hydrochloride salts 
with pH 5–6 because an alkaline pH destabilizes local anaesthetic 
solutions. Alteration of pH influences the rate of onset. For example, 
carbonated lidocaine favours the un-ionized molecule and has a faster 
onset of action whereas acidic tissue enhances ionization and reduces the 
onset and efficacy of local anaesthetics. 
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ENANTIOMER PHARMACOLOGY  
Bupivacaine is a chiral molecule consisting of two structurally 
similar, non-superimposable, mirror images called enantiomers. The 
nomenclature of enantiomers is based on the Cahn-Ingold-Prelog priority 
rules whereby the smallest atom is placed to the rear of the central atom 
about which the molecule rotates, and the sequence of the remaining three 
atoms is determined. For example, an increase in atomic mass in a 
clockwise direction is indicative of an S (sinistra) or laevo enantiomer 
whereas an increase in atomic mass in an anticlockwise direction is 
indicative of an R (rectus) or dextro enantiomer. 
Levobupivacaine is the S (–) or laevo enantiomer of bupivacaine 
whereas ropivacaine is a single enantiomer from the same series as 
bupivacaine, but with a propyl rather than a butyl group. 
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INDIVIDUAL LOCAL ANAESTHETIC 
PHARMACOLOGY  
Bupivacaine 
  Bupivacaine is a chiral compound, used clinically for 50 years. 
Initial benefits of bupivacaine were sensory-motor separation and 
minimal tachyphylaxis, unlike repeated doses of lidocaine. However, 
inadvertent intravenous administration of bupivacaine may result in 
systemic toxicity (see Local Anaesthetic Toxicity below) although 
addition of adrenaline may reduce this. 
 Levobupivacaine  
The laevo enantiomer of bupivacaine with the same molecular 
structure. Potency is less than bupivacaine but greater than ropivacaine. 
Both single enantiomers are less toxic than racemic bupivacaine. 
Ropivacaine 
A single enantiomer. Substitution of a propyl for the butyl side 
chain of levobupivacaine confers less lipid solubility and greater sensory 
motor separation. 
 
 
44 
 
Lidocaine  
This is the most popular local anaesthetic as it is safe, rapidly 
metabolized, and has a short duration of action. Efficacy is enhanced 
markedly by addition of  adrenaline. A testament to the relative safety of 
the use of lidocaine is the fact that the drug is used systemically as a class 
1b antiarrhythmic and in the treatment of chronic pain that is refractory to 
alternative approaches. 
Prilocaine 
This is less toxic than lidocaine, with a high clearance, attributable 
to metabolism in lung and kidneys and liver. It is associated with 
methemoglobinaemia at doses greater than 600 mg. The best application 
of prilocaine is as a 0.5% concentration, the provision of Bier’s block for 
manipulation of wrist fractures. Prilocaine is contained in a eutectic 
mixture with lidoacaine (EMLA) for topical anaesthesia. A 2% 
formulation is also available for spinal anaesthesia. 
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LOCAL ANAESTHETIC TOXICITY 
 Early Clinical Reports In 1979, Albright reported six cases of 
cardiac arrest without prodromal symptoms secondary to local anaesthetic 
toxicity. Four years later, he presented to the U.S. Food and Drug 
Administration (FDA) 53 cases of inadvertent intravascular injection of 
bupivacaine or etidocaine associated with prolonged and difficult 
resuscitation, 35 during pregnancy, and resulting in 24 deaths. The 
overriding clinical impression at that time was that toxicity secondary to 
bupivacaine appeared to be considerably out of proportion to its clinical 
potency relative to lidocaine, and, indeed, changes in anaesthetic practice 
such as needle aspiration, slow incremental injection and catheter 
insertion did much to reduce subsequent mortality. Scientific 
Investigations Animal studies indicated that the dextro enantiomer of 
bupivacaine was considerably more toxic than the laevo enantiomer. In 
electrophysiology experiments, dextro-bupivacaine attenuated the 
maximum upstroke velocity of the action potential (Vmax) and 
lengthened action potential duration (APD), and in isolated small animal 
hearts it induced QRS widening, increasing both atrioventricular (AV) 
conduction time and arrhythmias. In order to mimic inadvertent 
intravascular  injection, lidocaine, bupivacaine, ropivacaine and 
levobupivacaine were infused into instrumented, conscious sheep in 
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several studies designed to measure the cardiac and cerebral responses to 
systemic toxicity. The rank order of local anaesthetic dose needed to 
induce convulsions, arrhythmias, cardiac arrest and death was 
consistently: lidocaine > ropivacaine > levobupivacaine > bupivacaine. 
Importantly, arrhythmias induced by ropivacaine and levobupivacaine 
were more likely to revert to sinus rhythm, indicating that resuscitation 
may be easier in patients receiving these drugs. 
  Human Volunteer Studies Results from animal studies cannot 
necessarily be translated to humans. Therefore, in order to measure the 
cardiovascular effects of local anaesthetics, bupivacaine, ropivacaine and 
levobupivacaine were infused into  human volunteers in a series of 
studies using cardiac output monitoring until prodromal symptoms such 
as  paraesthesiae, visual impairment, light-headedness or tinnitus 
occurred. The rank order of reduced ejection fraction was bupivacaine > 
levobupivacaine = ropivacaine. Thus, data from animal and human 
volunteer studies suggest that levobupivacaine and ropivacaine both 
exhibit a stereospecific effect on cardiac arrhythmogenesis, cardiac 
mechanical function and resuscitation. Systemic Toxicity 
Levobupivacaine and ropivacaine were introduced into clinical practice 
because both drugs showed equivalent potency for nerve block compared 
to bupivacaine but a greater therapeutic index from animal studies. 
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However, systemic toxicity still remains a problem in clinical practice. 
Reasons for this include an increase in the practice of upper limb block, 
increased surgical use of local anaesthetics in high volumes for 
procedures such as tissue infiltration and tumescentanaesthesia, use of 
high-concentration compound local anaesthetic mixtures in the United 
States, inappropriate use of medical devices and administration of 
levobupivacaine and ropivacaine at doses greater than those 
recommended by the manufacturers. Upper limb block is associated with 
a greater incidence of toxicity than lower limb or neuraxial block. For 
example, the incidence of convulsions secondary to epidural anaesthesia 
has been estimated at 1 in 8435, compared to 1 in 827 for axillary block, 
and 1 in 130 for supraclavicular and interscalene block. Tumescent 
anaesthesia for liposuction using doses of lidocaine >50 mg kg−1 has 
been associated with a mortality rate between 1 in 5000 to 10 000. Deaths 
have also been reported after application of 6–10% lidocaine and 
tetracaine compound local anaesthetic cream with cellophane wrapping to 
the legs before laser hair removal. In the UK, three patients died after 
unintentional connection of epidural infusions to intravenous lines, also 
between January 2005 and May 2006, the National Patient Safety Agency 
(NPSA) identified more than 346 incidents with epidural infusions which 
resulted in harm to patients. Most importantly, introduction of new ‘safer’ 
local anaesthetic drugs has encouraged some practitioners to administer 
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higher doses of local anaesthetics than those recommended by drug 
manufacturers, narrowing the therapeutic window, and paradoxically 
increasing the risk of systemic toxicity. 
Mechanisms of Systemic Toxicity Direct injection into the 
vasculature (especially arterial injection in the head and neck) can lead to 
blindness, aphasia, hemiparesis, ventricular arrhythmias including 
fibrillation, convulsions, respiratory depression, coma or cardiac arrest. 
The most potent local anaesthetics have the highest tendency to cause 
systemic toxicity. For example, bupivacaine is more toxic than lidocaine. 
Cardiovascular effects are caused by blockade of cardiac VASCs and K+ 
channels. Levobupivacaine and ropivacaine are thought less likely to 
interact with cardiac VASCs. Convulsions may be caused by the 
blockade of GABA A receptors in the CNS and respond to positive 
modulators of GABA A receptor function (barbiturates, propofol and 
benzodiazepines). Involvement of mitochondria in local anaesthetic 
toxicity was proposed when a patient with carnitine deficiency showed 
marked sensitivity to a low dose of bupivacaine, suggesting that local 
anaesthetics interfere with mitochondrial energy functions. Animal 
experiments and many case reports have shown the benefits of Intralipid 
infusion during resuscitation following local anaestheticinduced cardiac 
arrest. 
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MANAGEMENT OF SEVERE LOCAL ANAESTHETIC 
TOXICITY 
       Treatment of systemic toxicity is outlined in the guidelines produced 
by the Association of Anaesthetists of Great Britain and Ireland 
(AAGBI). Recognition of the prodromal symptoms, such as agitation and 
disruption of sensory perception, is essential in order to instigate full life 
support measures. Immediate management should follow the Airway, 
Breathing, Circulation (ABC) mnemonic of resuscitation as outlined by 
the UK Resuscitation Council. Seizures should be controlled with small 
doses of thiopental, propofol or midazolam, depending on what is at 
hand. Hypoxaemia, hypercapnia and acidosis should be avoided because 
they all suppress myocardial function. If cardiac arrest occurs, 
cardiopulmonary resuscitation (CPR) should be started using standard 
protocols, but it should be recognized that arrhythmias may be very 
refractory. If so, consideration should be given to using an intravenous 
bolus dose of 20% Intralipid 1.5 mL kg−1 over 1 min followed by an 
infusion of 15 mL kg h−1. If still unresponsive, a further two boluses may 
be given and the infusion rate doubled . The role of adrenaline in 
lipidbased resuscitation from local anaesthetic-induced cardiac arrest is 
the subject of debate and is still to be resolved. Several case reports now 
allude to the success of Intralipid in both paediatric and adult 
resuscitation.   
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Prevention of Severe Local Anaesthetic Toxicity  
Regional blocks should always be performed in an area equipped 
to deal with cardiorespiratory collapse, such as an anaesthetic room or 
block room within the theatre suite. 
The age, weight and infirmity of the patient should be taken into 
account, and doses adjusted accordingly. 
   Syringes of local anaesthetics and perineural and epidural 
infusions should be labelled clearly. Use of premixed sterile solutions is 
encouraged. 
  Gentle aspiration of the syringe should precede every injection, but 
anaesthetists should be aware that negative aspiration does not guarantee 
extravascular positioning of the needle tip – false negatives do occur.  
 Both during and after drug administration, the anaesthetist must 
keep talking to the patient.  
 An appropriate test dose should be given depending on the 
situation. For example, a test dose of 3 mL of ‘epidural’ bupivacaine 
0.5% (15 mg) injected accidentally into the intrathecal space will provide 
a definitive outcome – spinal anaesthesia. In contrast, injection of 0.5 to 1 
mL during a perineural block under ultrasound is usually sufficient to 
differentiate between intraneural and extraneural injection.  
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Examples of alternative epidural test doses are lidocaine 2% or 
adrenaline 15 μg, but neither test is specific or sensitive 
   Ultrasound allows visualization of the position of the needle or 
catheter, their relationship to other structures – both nerves and large 
blood vessels – and the spread of local anaesthetic  solution, although no 
definitive evidence  exists yet that its use reduces overall complication 
rates. 
EMERGING LOCAL ANAESTHETIC APPROACHES  
Imaging and Local Anaesthesia Ultrasound has become an 
important 2-D technique for guiding regional anaesthesia. Direct 
visualization of peripheral nerves, blood vessels and muscle is now 
possible during needle insertion both in-plane and out-of-plane of the 
ultrasonic beam. Local anaesthetic is deposited precisely around nerves 
using the hydrolocation technique whereby 1-mL boluses of local 
anaesthetic are used to distend connective tissue. The spread of local 
anaesthetic on a standard ‘B-Mode’ image is relatively easy to see and is 
quite distinct from the intraneural swelling characteristic of direct 
intraneural injection in laboratory preparations. However, despite 
undoubted improvements in block efficacy, no evidence as yet exists to 
demonstrate that the incidences of inadvertent intraneural or intravascular 
injection have declined TRP Channels and Pain There has been a great 
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deal of recent interest in targeting ion channels of the transient receptor 
potential (TRP) family to produce analgesia. Noxious heat activates TRP 
channels of the TRPV1 subtype in primary afferent nociceptive neurones. 
TRPV1 channel activation triggers the influx of Na+ and Ca2+ ions, 
leading to depolarization and activation of VASCs. The resulting action 
potentials in pain fibres trigger the burning pain stimulus. TRPV1 
channels are also activated by the vanilloid capsaicin, a pungent 
substance extracted from chilli peppers. Other subtypes of TRP channel 
(TRPM8 and TRPA1) appear to be stimulated by noxious cold. There is 
interest in antagonists of TRP channels as potential analgesic drugs. 
Recent studies also demonstrate that TRPV1 channels can flux the 
positively charged quaternary lidocaine molecule QX-314. The drug is 
permanently charged and therefore cannot pass across the membrane of 
nociceptive neurones without an aqueous passage. Stimulation of TRPV1 
channels by capsaicin provides a conduit for entry of QX-314 into pain 
fibres. Once inside neurones, the charged molecule binds to the local 
anaesthetic binding site within VASCs and inhibits action potentials. 
There is interest in this approach for targeting local anaesthesia to 
nociceptive neurones, thereby increasing the selectivity of block. Animal 
studies demonstrate that this method provides prolonged analgesia with 
much less motor block than is caused by equivalent analgesia using 
lidocaine. 
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TOXICITY OF LOCAL ANAESTHETICS 
The toxicity of LA agent mainly affects the CNS and CVS. The 
subconvulsive doses does not cause the circulatory depression, but may 
depress the CNS. However, like other drugs, the toxicity of LA agents is 
not the mere extension of their therapeutic action but has a distinct 
mechanism. It depends on the speed of vascular absorption, and trouble 
starts when the absorption and elimination of the drug does not balance. 
The occurrence of toxicity of LA agent is not related to the concentration 
of the solution injected, but rather to the total dose of drug. Similarly the 
site of injection and its vascularity also affect the speed of absorption of 
LA agent, as well as its toxicity. The relative overdose for a given plasma 
concentration in case of very young or old patients is not due to their 
raised sensitivity. So, widespread field block and excessive surface 
application should be avoided in such group of patients. The cause of 
toxicity of LA agents in correctly administered dose is due to gradual 
accumulation in body due to the continuous or repeated administration of 
gradual accumulation in body due to the short acting drugs. So, long 
duration of bupivacaine and rapid elimination of etidocaine has clear 
advantage for continuous infusion. 
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CNS Toxicity  
Subjective signs 
These are: light headedness, dizziness, visual and auditory 
disturbances such as difficulty in focusing and tinnitus, disorientation and 
drowsiness. 
Objective signs 
These are: shivering, twitching, tremor, convulsion, respiratory 
depression, respiratory arrest, coma and death. There is an inverse 
relationship between the intrinsic anaesthetic potency of a LA agent and 
the doses required to induce CNS toxicity.  An increase in PaCO2 
decreases the convulsive threshold level of local anaesthetic agent by 
approximately 50%. The explanation is like that an elevation of PaCO2 
increases the cerebral blood flow a and so more anaesthetic agent is 
delivered to the brain rapidly. In addition, the diffusion of CO2 in the 
neural cell decreases the intracellular pH and thus facilitates the 
conversion of unionised form of the drug to ionised form within the cell, 
which only bind with the hydrophobic receptor site of the intracellular 
part of Na+ channel. Thus the cationic or ionized form does not cross the 
nerve cell membrane, so that ion trapping occurs and increases CNS 
toxicity. On the other hand, hypercapnia or acidosis decreases the plasma 
protein binding capacity of LA agents, and so increases the proportion of 
free drug available for diffusion into the brain. Seizure and CNS 
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depression again produce hypoventilation and respiratory acidosis, which 
further exacerbates the CNS toxicity establishing a vicious cycle. So, in 
local anaesthetic toxicity prompt assisted ventilation correcting acidosis is 
essential. 
 Cardiovascular toxicity 
 The direct cardiac effects of LA agents are: 
i. The LA agents decrease the rate of depolarisation in the fast 
conducting tissues such as Purkinje fibres and ventricular muscles. 
This reduction in the rate of depolarisation is believed to be due to 
decrease in the availability of fast Na+ channel in cardiac cell 
membrane and myocardial depression. 
ii. The duration of action potential and effective refractory (Fact file-
II) period is decreased, leading to ventricular tachycardia, 
fibrillation, ectopics, etc. 
iii. The ratio of effective refractory period and duration of action 
potential is increased. 
iv. Bupivacaine depresses the rapid phase of depolarisation to a 
greater extent than lignocaine. 
v. The rate of recovery from the use dependent block is slower in 
bupivacaine than lignocaine. This slow rate of recovery results in 
incomplete restoration of some Na+ channel and less availability of 
it between two subsequent action potential. In contrast, recovery 
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from lignocaine is complete. The effect of this differential recovery 
explains the antiarrhythmic properties of lignocaine and 
arrhythmogenic property of bupivacaine. 
vi. The LA agents prolong the conduction time and thus increase the 
PR interval and the duration of QRS complex. 
vii. The Extremely high concentration of local anaesthetic agents 
depress the spontaneous pacemaker activity in the SA node, 
causing sinus bradycardia and sinus arrest. 
viii. All the LA agents have dose dependent negative inotropic action 
on cardiac muscles. This negative inotropic effect on myocardium 
is due to the inhibition of release of Ca2+ from the sarcoplasmic 
reticulum and also inhibition of Na+ currents. 
 Local tissue toxicity 
The volume and concentration of LA agent used clinically rarely 
produce localized nerve damage. But the evidence of local neurotoxicity, 
caused by LA agents is occasionally seen and depends on the type of 
agent used (the ester linked may be more neurotoxic than the amide 
linked anaesthetics), its concentration, the site of injection, osmolarity 
and pH of the solution, and the presence of other certain additives with it 
such as vasoconstrictors, antioxidants, preservatives, etc. Electron 
microscopy studies indicate that the perineuronium, Schwann cells and 
axons themselves may be damaged due to the neurotoxicity of LA agents. 
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The advanced age and diseased states of the nervous tissue also enhance 
the susceptibility of LA agents to the neurotoxicity. The neurotoxicity in 
clinical practice is most commonly seen with spinal anaesthesia. 
Adrenaline has also been investigated as a possible contributor to the 
local anaesthetic neurotoxicity. The suspected mechanism is decreased 
intraneural blood supply due to vasoconstriction by adrenaline. 
Admixture of LA agent with antioxidant, such as sodium bisulphite, in 
the presence of a low pH has also been shown to be neurotoxic. So, for a 
safer and more effective alternative to these commercial solutions, 
adrenaline may be added to local anaesthetics freshly before use. There 
are many reports of inadvertent needle penetration of the globe of eyeball 
during peribulbar or retrobulbar block which is followed by injection of 
local anaesthetic agent in clinical concentration intraocularly. But, the 
retina which is a specialized nerve tissue did not undergo toxic changes in 
these circumstances. Concentration of lignocaine required to produce 
irreversible conduction blockade and permanent damage of nerve fibre in 
experimental conditions overlap the concentration which is used 
clinically, such as 2% lignocaine. But, practically this does not happen. 
This is because LA agents are not applied clinically directly to the nerve 
fibre in such concentrations.  So, although the LA is injected clinically at 
a much higher concentration than their physiological effective range, but 
they are usually diluted in the tissues during the process of transport from 
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the site of injection to the site of action and hence no harm is produced. If 
this dilution does not occur then a permanent neural deficit do result. 
Thus, application of 5% lignocaine in hyperbaric solution, through a 
narrow intrathecal catheter is associated with  high incidence of cauda-
equina syndrome. However, anaesthetists should keep in mind that the 
concentrations of marketed LA solutions are neurotoxic and their dilution 
in tissue is essential for safe use. Continuous spinal anaesthesia, using a 
micro catheter is associated with a high incidence of neurotoxicity, such 
as radicular irritation, cauda equina syndrome, etc. Studies suggest that 
microcatheter facilitates a localized deposition of high concentration of 
drug which are inadequately dispersed or diluted in the CSF, leading to 
direct contact of a high concentration of drug around the sacral roots and 
consequent neurotoxicity. 
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ADDITIVES 
                 The most commonly used adjuvant drugs with LA agents to 
increase their efficacy and duration of action are adrenaline, 
noradrenaline, felypressin, hyaluronidase and sodium bicarbonate. 
ADRENALINE 
By its α-stimulant action, adrenaline constricts the vessels at the 
site of injection of LA agents and thus reduces its absorption through the 
blood. So, the local anaesthetic action is prolonged, the depth of block is 
increased and the toxicity of drug is reduced. As a whole, the quality and 
reliability of the block are improved. Adrenaline added to the local 
anaesthetic solution also provides a marker for inadvertent intravascular 
injection of it. Other vasoconstrictors, such as norepinephrine, 
phenylephrine, etc., also have been used with LA agents, but they are not 
superior than adrenaline in this purpose. The α-adrenergic receptors in 
spinal cord are also known to activate the endogenous analgesic 
mechanism and thus adrenaline also increases the depth of analgesic 
action of LA agents in the central neuraxial block. Therefore, where 
prolonged block is necessary, the addition of adrenaline with local 
anaesthetic agents reduces the number of repeated doses of it, and thus 
delays the onset of chronic toxicity and tachyphylaxis of the LA agents. 
Particularly, it is very valuable in highly vascular areas, e.g intercostals 
space, pelvic floor etc., than the less vascular areas e.g. epidural space. 
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So, the aim of use of adrenaline differs from time to time. Sometimes it is 
to reduce the toxicity and sometimes it is to prolong the effect of LA 
agent. However, the presence of adrenaline in the LA solution makes the 
injection more painful. It also increases the chances of subsequent local 
tissue oedema and necrosis, as well as delays the wound healing by 
reducing the oxygen supply and enhancing the O2 consumption in the 
injected area. Sometimes, the LA agent with adrenaline may raise BP and 
promote arrhythmia in susceptible individuals. The effect of adrenaline 
on long acting drugs, such as bupivacaine and etidocaine are less marked. 
In dentistry, always some form of vasoconstrictor is essential with most 
LA agents to diminish the bleeding during extraction of teeth. The 
inclusion of adrenaline in LA solution necessitates addition of 
antioxidants such as sodium metabisulphite or ascorbic acid. This is 
because adrenaline is stable in acidic solution only and this is provided by 
Na metabisulphite or ascorbic acid. But these agents reduce more the pH 
of LA solution, even less than 4 and increases the toxicity. In Britain, 
bupivacaine with adrenaline contains fewer additives and the pH is 
around 4.5Dose Adrenaline should not be used in concentration more 
than 5 µg/ml (1:200000) which causes optimal degree of 
vasoconstriction. But, in dentistry as the total volume of drug used is 
small, so a higher concentration of adrenaline, such as 12.5 µg/ml 
(1:80000) is used. When injected IV accidentally, adrenaline is more 
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dangerous than the local anaesthetic itself. If the total volume of local 
anaesthetic agent containing 100 to 150 µg of adrenaline is inadvertently 
injected intravenously, then it produces severe systemic effects such as 
tachycardia, arrhythmia, ventricular fibrillation, sweating, etc. for a brief 
duration. But, in a correctly placed block adrenaline is absorbed slowly 
from the tissue and no systemic effect occurs. Adrenaline is 
contraindicated in patient (i) taking certain antihypertensive drugs, (ii) 
taking tricyclic antidepressants, (iii) with thyrotoxicosis, (iv) for digital 
block, (v) for penile block, etc. Its use may be dangerous in epidural 
analgesia or anaesthesia for anterior spinal artery syndrome. 
NORADRENALINE 
It is also an α stimulant, but less potent than adrenaline. So, in 
dentistry for the purpose of vasoconstriction and to reduce bleeding 
noradrenaline in a high dose such as 20 to 40 µg/ml (1:50000 to 1:25000) 
may be necessary. But this high doses of noradrenaline produces severe 
hypertension. 
FELYPRESSIN 
It is a synthetic polypeptide, related to vasopressin. As a 
vasoconstrictor it is also suitable agent like adrenaline, but less toxic. For 
example, it produces no changes in CVS in conditions where adrenaline 
in the dose of 12.5 is likely to produce tachycardia. With prilocaine it is 
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more effective in prolonging the action of LA agents with less toxicity 
than adrenaline. 
HYALURONIDASE 
The enzyme hyaluronidase is frequently added to local anaesthetic 
agents for regional opthalmic anaesthesia to promote the spread of drug 
(LA agents) through the intraorbital tissues. It breaks down collagen 
bonds and thus allows the anaesthetic solution to spread across the fine 
septal barriers of connective tissue. This action is accomplished by the 
reversible hydrolysis of hyaluronic acid which is the cement substance of 
intercellular connective tissues. However, to maintain the full activity of 
the product, refrigeration is important. Prolonged exposure of 
hyaluronidase to room temperature (> 48 hours) results in deterioration of 
enzyme potency. Autoclaving of solutions also results in destruction of 
the enzyme strength.  Hyaluronidase is added to the local anaesthetic 
solution in a concentration of 7.5 to 15 turbidity units/ml. Higher 
concentrations of it have no added advantage. Prior to its introduction, the 
volume of local anaesthetic agent injected into the orbital cavity for 
opthalmic regional anaesthesia was limited. This is due to the raised 
intraorbital and subsequently intraocular pressure as the LA solution does 
not spread quickly. Then the greatly improved standards of effective local 
anaesthesia for opthalmic surgery (especially cataract extraction), without 
compromising the intraocular pressure was made possible by adding 
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hyaluronidase with the large volumes of LA injection. However, 
hyaluronidase reduces the duration of anaesthesia. This is because it 
increases the spread of LA agent and absorption and subsequently 
increases its absorption through the blood vessels. But, adrenaline 
reverses that tendency. It has allergic potential and is more myotoxic than 
enzyme free solutions. However, the use of hyaluronidase enzyme is not 
a substitute for less precise anatomical knowledge and poor technique for 
high quality opthalmic regional anaesthesia as it only facilitates the 
spread of LA injection along the path of least resistance of tissue. So, the 
LA solution should be placed accurately within the appropriate 
compartment. Hyaluronidase does not enhance brachial plexus block, nor 
does it influence the plasma levels of local anaesthetics agents. 
Sodium Bi-carbonate 
The tissue penetration and onset of action is enhanced by adjusting 
the pH of local anaesthetic solution towards the unionised base by the 
addition of small amounts of sodium bicarbonate. For each agent there is 
a pH at which the amount of unionised molecules (which only penetrate 
the cell membrane) of LA agent in solution becomes saturated. Increase 
in pH beyond that point results in the precipitation of the free base after 
which no further clinical benefit is achieved. Infact, a nuisance factor, 
such as blockage of needles by free base precipitate creates problems. 
There are also many literatures which are equivocal about the 
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effectiveness of pH adjustment of LA agents by just mere adding 
NaHCO3 in LA solution in various clinical circumstances. So many 
anaesthetists fail to see any benefit in their practice, after pH adjustment 
of local anaesthetics with sodium bicarbonate. However, alkalinised 
solutions should be used within 6 hours of their preparation. There is 
definite lesser pain during injection, when bicarbonate is used with LA 
agents. 
pH Adjustment of Local Anaesthetic Solution Addition of 
NaHCO3 to the LA solution causes rapid onset of action. This is because 
increase of pH increases the amount of drug in unchanged base form and 
enhances its diffusion across the cell membrane, resulting in a more rapid 
onset of action. It happens with bupivacaine also. But till now, there is a 
controversy about the efficacy of technique of carbonation (just merely 
adding NAHCO3 in acidic LA solution. I do not believe in this process 
because if causes precipitation) and pH adjustment of  LA agent. 
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REVIEW OF LITERATURE 
1. The study titled Reduced hemidiaphragmatic paresis with 
extrafascial compared with conventional intrafascial tip 
placement for continuous interscalene brachial plexus block: a 
randomized, controlled, double-blind trial by E. Albrecht1*, I. 
Bathory1, N. Fournier2, A. Jacot-Guillarmod1, A. Farron3 and R. 
Brull4.. Seventy patients undergoing elective major shoulder 
surgery under general anaesthesia were randomized to receive an 
ultrasound-guided CISB plexus block for analgesia with the 
catheter tip placed either within (intrafascial group) or 
immediatelyoutside (extrafascial group) the brachial plexus sheath 
midway between the levels of C5 and C6.. The primary outcome 
was hemidiaphragmatic paresis measured by M-mode 
ultrasonography on postoperative day (POD) 1. Secondary 
outcomes included forced vital capacity, forced expiratory volume 
in 1s, and rest pain scores. The incidence of hemidiaphragmatic 
paresis on POD 1 was signiﬁcantly reduced in the extrafascial 
group .Placement of the catheter tip immediately outside of the 
brachial plexus sheath reduced the incidence of 
hemidiaphragmatic paresis on POD 1 associated with ultrasound-
guided CISB while providing effective analgesia after major 
shoulder surgery 
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2. The study titled Randomized Comparison of Extrafascial 
Versus Subfascial Injection of Local Anesthetic During 
Ultrasound-Guided Supraclavicular Brachial Plexus Block by 
T. Sivashanmugam; Suja Ray; M. Ravishankar; V. Jaya; E. 
Selvam; Manoj Kumar Karmakar.The optimal site for local 
anesthetic injection during an ultrasound-guided supraclavicular 
brachial plexus block (BPB) is not known. They tested the 
hypothesis that local anesthetic injected deep to the “brachial 
plexus sheath” during supraclavicular BPB would produce faster 
onset of surgical anesthesia than an injection superﬁcial to the 
sheath.Injection of local anesthetic deep to the brachial plexus 
sheath at the supraclavicular fossa, under ultrasound-guidance, 
results in faster onset of surgical anesthesia and prolonged 
duration of postoperative analgesia than an injection superﬁcial to 
the sheath. 
3. The study titled  Effect of  local anaesthetic volume (20 vs 5 ml) 
on the efﬁcacy and respiratory consequences of ultrasound-
guided interscalene brachial plexus block by S. Riazi1, N. 
Carmichael1, I.Awad 1,  R. M. Holtby2  and C. J. L. 
McCartney1*. Interscalene brachial plexus block (ISBPB) is an 
effective nerve block for shoulder surgery. However, a 100% 
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incidence of phrenic nerve palsy limits the application of ISBPB 
for patients with limited pulmonary reserve. They examined the 
incidence of phrenic nerve palsy with a low-volume ISBPB 
compared with a standard-volume technique both guided by 
ultrasound. Forty patients undergoing shoulder surgery were 
randomized to receive an ultrasound-guided ISBPB of either 5 or 
20 ml ropivacaine 0.5%. General anaesthesia was standardized. 
Both groups were assessed for respiratory function by sonographic 
diaphragmatic assessment and spirometry before and after 
receiving ISBPB, and after surgery. Motor and sensory block, 
pain, sleep quality, and analgesic consumption were additional 
outcomes. The incidence of diaphragmatic paralysis was 
signiﬁcantly lower in the low-volume group compared with the 
standard-volume group. The use of low-volume ultrasound-guided 
ISBPB is associated with fewer respiratory and other 
complications with no change in postoperative analgesia compared 
with the standard-volume technique 
4. The study titled Hemidiaphragmatic Paresis Can Be Avoided in 
Ultrasound-Guided Supraclavicular Brachial Plexus Block by 
Steven H. Renes; Hubertus H. Spoormans; Mathieu J. Gielen; 
Harald C. Rettig; Geert J. van Geffen.Supraclavicular brachial 
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plexus block is associated with 50% to 67% incidence of 
hemidiaphragmatic paresis as a result of phrenic nerve block. We 
examined whether ultrasound-guided compared with nerve 
stimulation supraclavicular brachial plexus block using 0.75% 
ropivacaine results in a lower incidence of hemidiaphragmatic 
paresis.In a prospective randomized observer-blinded controlled 
trial, 60 patients scheduled for elective elbow, forearm, wrist, or 
hand surgery under supraclavicular brachial plexus block without 
sedation were included. Supraclavicular brachial plexus block was 
performed with 20 mL of 0.75% ropivacaine using either 
ultrasound or nerve stimulation guidance. Ventilatory function was 
assessed by ultrasound examination of hemidiaphragmatic 
movement and spirometryNone of the 30 patients in the ultrasound 
group showed complete or partial paresis of the hemidiaphragm 
(95% conﬁdence interval, 0.00-0.14), whereas in the 
nervestimulation group, 15 patients showed complete paresis of 
the hemidiaphragm and 1 patient showed partial paresis of the 
hemidiaphragm (0% versus 53%, respectively; P < 0.0001). 
Ventilatory function (forced expiratory volume 1, forced vital 
capacity, peak expiratory ﬂow) was signiﬁcantly reduced in the 
nerve stimulation group compared with the ultrasound-guided 
group (P < 0.05). Two block failures occurred in the nerve 
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stimulation group compared with none in the ultrasound group (P 
= 0.49). No adverse effects occurred in either group.Ultrasound-
guided supraclavicular brachial plexus block, using 20 mL of 
0.75% ropivacaine with the described technique, is not associated 
with hemidiaphragmatic paresis. 
5. The study titled Decreasing the Local Anesthetic Volume From 
20 to 10 mL for Ultrasound-Guided Interscalene Block at the 
Cricoid Level Does Not Reduce the Incidence of 
Hemidiaphragmatic Paresis by Sanjay K. Sinha; Jonathan H. 
Abrams; John T. Barnett; John G. Muller; Bimalin Lahiri; Bruce 
A. Bernstein; Robert S. Weller.This prospective, randomized, 
double-blind study was designed to determine whether reduction 
in volume from 20 to 10 mL of ropivacaine 0.5% for ultrasound-
guided interscalene block might decrease the incidence of 
diaphragmatic paresis and preserve pulmonary function. Thirty 
patients scheduled for arthroscopic shoulder surgery were 
randomized to receive either 10 or 20 mL of ropivacaine 0.5% for 
interscalene block at the level of the cricoid cartilage. General 
anesthesia was administered for surgery, and the surgeon 
inﬁltrated lidocaine at the port sites. Hemidiaphragmatic excursion 
and pulmonaryfunction tests were measured before block, 15 mins 
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after block, and at the time of discharge from recovery room. 
Onset and duration of sensory dermatomal spread, motor block, 
pain scores, and analgesic consumption were recorded. 
Hemidiaphragmatic paresis occurred 15 mins after block 
performance in 14 of 15 patients in each group. At postanesthesia 
care unit discharge, 13 of 15 patients in each group continued to 
demonstrate hemidiaphragmatic paresis. Signiﬁcant reduction of 
spirometric values (forced vital capacity, forced expiratory volume 
at 1 sec, and peak expiratory ﬂow) occurred to a similar degree in 
both groups after block. Sensory dermatomal spread, motor block, 
pain scores, and analgesic consumption were not signiﬁcantly 
different between groups. Decreasing the volume for interscalene 
block from 20 to 10 mL did not reduce the incidence of 
hemidiaphragmatic paresis or impairment in pulmonary function, 
which persisted at discharge from recovery room. No signiﬁcant 
differences in quality or duration of analgesia were observed. 
6. The study titled Ultrasound-Guided Low-Dose Interscalene 
Brachial Plexus Block Reduces the Incidence of 
Hemidiaphragmatic Paresis by Steven H. Renes; Harald C. 
Rettig; Mathieu J. Gielen; Oliver H. Wilder-Smith; Geert J. van 
Geffen.Interscalene brachial plexus block is associated with 100% 
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incidence of hemidiaphragmatic paresis as a result of phrenic 
nerve block. We examined whether an ultrasound (US)-guided 
interscalene brachial plexus block performed at the level of root 
C7 versus a nerve stimulation interscalene brachial plexus block, 
both using 10 mL of ropivacaine 0.75%, resulted in a lower 
incidence of hemidiaphragmatic paresis. In a prospective 
randomized controlled trial, 30 patients scheduled for elective 
shoulder surgery under combined general anesthesia and 
interscalene brachial plexus block were included. Interscalene 
brachial plexus block using the same dose was performed using 
either US or nerve stimulation guidance of ropivacaine for both 
groups. General anesthesia was standardized. Ventilatory function 
was assessed using spirometry, and movement of the 
hemidiaphragm was assessed by US. Two patients in the US group 
showed complete paresis of the hemidiaphragm, but in the nerve 
stimulation group, 12 patients showed complete and 2 patients had 
partial paresis of the hemidiaphragm (13% versus 93%, 
respectively; P < 0.0001). Ventilatory function (forced expiratory 
volume at 1 second, forced vital capacity, and peak expiratory 
ﬂow) was signiﬁcantly reduced in the nerve stimulation group 
compared with the US-guided group (P < 0.05). One block failure 
occurred in the nerve stimulation group compared with none in the 
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US group. No adverse effects occurred in either group.  
Ultrasound-guided interscalene brachial plexus block performed at 
the level of root C7 using 10 mL of ropivacaine 0.75% reduces the 
incidence of hemidiaphragmatic paresis 
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MATERIALS AND METHODS 
 
The institutional ethical committee approval for the study was 
obtained. The informed written consent was obtained from the patients 
participating in the study was obtained. 
 
 DESIGN OF STUDY: Prospective Randomised Study 
 SAMPLE SIZE: 40 
 PARTICIPANTS: Patients posted for elective shoulder and 
clavicle sugeries. 
 INCLUSION CRITERIA: 
              Elective shoulder and clavicle surgeries with ASA I&II 
                   Both sexes 
                   Age :18-85 years 
 EXCLUSION CRITERIA: 
                  Patients  with history of bleeding disorders 
                  Patients on anticoagulant therapy 
             Patient’s refusal 
             Patients with local infection 
                  Patients with pregnency 
       Patients with known allergy to local anaesthetic drugs 
       Psychiatric illnesses 
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      Existing neurological deﬁcit in the upper limb 
       History of neck surgery or radiotherapy 
       Moderate to severe pulmonary disease 
METHODOLOGY 
Forty adult patients were divided into 2 equal groups of 20 subjects each 
• Extrafascial Injection Group (E): The ﬁnal needle tip position 
was 4 mm lateral to the brachial plexus sheath, at a level 
equidistant between C5 and C6 roots 
• Intrafascial Injection Group(C) :  The ﬁnal needle tip position 
was within the brachial plexus sheath in between the C5 and C6 
nerve roots 
All patients received 20ml of bupivacaine 0.5% with epinephrine 
1:200000 through the  block  needle,  injected in 5 ml increments with 
intermittent aspiration 
All patients undergone spirometry and hemidiaphragmatic 
assessment both pre and post procedure and onset of sensory and motor 
block was assessed before inducing GA 
GENERAL ANAESTHESIA 
Patient including both groups are premedicated with injection 
glycopyrolate 0.2mg and injection fentanyl 2mic/kg and induced with 
thiopentone 5-7mg/kg body weight slowly injected till loss of blink reflex 
and paralysed with injection atracurium (0.5mg/kg).After adequate 
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relaxation patient was intubated with adequate sized cuffed endotracheal 
tube and maintained with titrated dose of injection atracurium (0.1mg/kg) 
and sevoflurane and N2O: O2 1:1 
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PARAMETERS TO BE MONITORED 
 
The following parameters are assessed: 
 
• Hemidiaphragmatic paresis is confirmed under ultrasound 
guidance by M mode during forced inspiration and expiration pre 
and post procedure 
 Pre-procedure 
 
      Forced vital capacity (L) 
 
      Forced expiratory volume in 1 s (L) 
 
      Peak expiratory ﬂow (L s−1) 
  
 Post-procedure 
 
      Forced vital capacity (L)  
 
      Forced expiratory volume in 1 s (L) 
  
      Peak expiratory ﬂow (L s−1) 
 
 
 Percentage reduction 
 
 Forced vital capacity (%) 
 Forced expiratory volume in 1s (%) 
 Peak expiratory ﬂow (%) 
 Block related outcomes  
 Onset time of sensory block (min) 
 Onset time of motor block (min) 
 Post Op duration of analgesia (min) 
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 STATISTICAL TOOLS TO BE APPLIED: 
 
Means, standard deviation, percentages, student’s t-test and the 
Fisher’s exact test are used for statistical comparisons. P < 0.05 was 
considered significant. 
TABLE 1: Age Distribution 
Age GROUP C GROUP E 
<30 4 4 
31-40 10 4 
>40 6 12 
Total 20 20 
Mean 36.9 39.35 
SD 6.15 8.17 
P 0.291  Not significant 
 
P value was calculated with Student ‘T’ test. The mean age of 
patients in both groups are found to be comparable and statistically 
insignificant. 
 
 
 
 
 
On random allocation, patients of age 18-85 yrs are taken into study. 
35
36
37
38
39
40
Group C  Group E
Age
age
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TABLE 2: SEX DISTRIBUTION 
 
 
 
 
P value was calculated with Chi Square test. The sex distribution of 
both the groups are found to be comparable and statistically insignificant 
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Sex GROUP C GROUP E 
Male 9 11 
Female 11 9 
Total 20 20 
P 0.752   Not significant 
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TABLE 3: WEIGHT 
BMI GROUP C GROUP E 
<24 6 4 
>24 14 16 
Total 20 20 
Mean 24.27 25.56 
SD 1.52 1.59 
P 0.561 Not significant 
 
P value was calculated with Student ‘T’ test. The weight of the 
patients in both the groups are compared and found to be statistically 
insignificant. 
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TABLE 4: ASA 
ASA GROUP C GROUP E  
ASA 1 11 10 
2 9 10 
Total 20 20 
Mean 1.45 1.5 
SD 0.51 0.513 
P 0.759 Not significant 
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HEMIDIAPHRAGMATIC MOVEMENT ASSESSMENT 
Hemidiaphragmatic excursion before and 30 min after the ISB 
procedure was assessed with a low-frequency curvilinear transducer using 
a subcostal approach. Brieﬂy, patients were examined in the lying 
position and the hemidiaphragm was identiﬁed as an hyperechoic line, 
with breathing-related movements using the liver or spleen as an acoustic 
window. The hemidiaphragmatic excursion was measuredby real-time M-
mode ultrasonography from the restingexpiratory position to a deep and 
quiet inspiration. 
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TABLE 5: Pre-procedure 
PRE PROCEDURE 
GROUP C GROUP E   
MEAN SD MEAN SD P SIGNIFICANCE 
Forced vital 
capacity(L) 
4.435 0.57608 4.33 0.377108 0.4938 Not significant 
Forced expiratory 
volume in 1s (L) 
3.42 0.289464 3.585 0.306551 0.0893 Not significant 
Peak expiratory 
flow (L/s) 
7.465 0.849319 8.295 0.342552 0.0002 Not significant 
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TABLE 6: POST PROCEDURE 
POST 
PROCEDURE 
GROUP C GROUP E   
Mean SD Mean SD 
P 
value 
Significance 
Forced vital 
capacity (L) 
3.36 0.445327 3.94 0.2891 <0.0001 Significant 
Forced expiratory 
volume in 1 s (L) 
2.445 0.366312 2.935 0.511216 0.001 Significant 
Peak expiratory 
flow (L s−1) 
6.15 0.57078 7.475 0.340085 <0.0001 Significant 
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TABLE 7: PERCENTAGE REDUCTION 
PERCENTAGE 
REDUCTION 
GROUP C GROUP E 
  
MEAN SD MEAN SD P Significance 
Forced vital capacity 
(L) 
33 3.621573 15.85 2.345769 <0.0001 Significant 
Forced expiratory 
volume in 1 s (L) 
28.6 3.118704 15.75 2.268201 <0.0001 Significant 
Peak expiratory flow 
(L s−1) 
23.7 1.949359 8.65 1.755443 <0.0001 Significant 
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TABLE 8: BLOCK RELATED OUTCOMES 
 
GROUP C GROUP E 
  
 
MEAN SD MEAN SD P Significance 
Onset of sensory 12.35 1.843195 19.25 2.244877 <0.0001 Significant 
Onset of motor 8.35 2.41214 17.2 1.542384 <0.0001 Significant 
Post op 
Analgesia 
1132.6 2.233713 1000.4 48.61276 <0.0001 Significant 
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RESULTS 
There were no significant differences between the groups with 
respect to age, weight, preoperative heart rate, blood pressure, respiratory 
rate and duration of stay in recovery room. Males and females were 
almost evenly distributed between the two groups. 
The rate of hemidiaphragmatic paresis was signiﬁcantly reduced in 
the extrafascial injection group (25% [95% CI: 8–46%]) compared with 
the conventional injection group (95% [95% CI: 73–99%]; P<0.0001) 
All respiratory outcomes were signiﬁcantly preserved in the 
extrafascial injection group. 
A conventional injection was associated with a faster onset and 
longer duration of post op analgesia 
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DISCUSSION 
          This study suggests that an extrafascial injection reduces the rate of  
hemidiaphragmatic paresis and impact on respiratory function, while 
providing similar analgesia compared with a conventional injection for 
USG-guided ISB. Prolonged onset times of sensory and motor blocks in 
the extrafascial injection group are observed but insignificant for 
analgesic purposes, as both the groups are equally satisﬁed with 
analgesia. Previous attempts have focused on reducing the volume of 
local anaesthetic injected inside the brachial plexus sheath  for  reducing  
hemidiaphragmatic  paresis. Reports  say that reducing the volume of 
local anaesthetic from 20 to 10ml or 5ml reduced the rate of  
hemidiaphragmatic paresis to  95%  or  50%,  respectively. In the present 
study, we were able to reduce the rate of hemidiaphragmatic paresis to 
25% by injecting  outside of  the brachial plexus sheath. Extrafascial 
injection can be easily  done  by  inserting the needle tip a short distance 
from the lateral border of the brachial plexus, while ensuring that the 
local anaesthetic injectate spreads towards the nerve roots. The study has 
several limitations.The  results cannot be used to predict which patients 
are at risk  to  develop hemidiaphragmatic paresis despite an extrafascial 
injection. In the presence of pre-existing lung disease this is an important 
consideration when performing ISB. Another limitation of this study is 
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that hemidiaphragmatic movement or excursion  was measured only  30 
min after injection of local anaesthetic. There are chances that we have 
failed to capture delayed-onset hemidiaphragmatic paresis. Further, we 
did not repeat ultrasonographic hemidiaphragmatic assessment and 
respiratory tests after ISB.  Therefore we were unable to determine 
duration of hemidiaphragmatic paresis.  
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CONCLUSION 
 
In conclusion, ultrasound-guided ISB with an extrafascial  injection 
reduces  the rate of  hemidiaphragmatic paresis and its impact on 
respiratory function while providing similar analgesia, as compared to 
conventional injection. 
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PROFORMA 
 
NAME          :                        I.P.NO:                                 ASA: 
AGE & SEX:                                                                                
WEIGHT    : 
DATE & TIME OF ADMISSION:             DATE & TIME OF DISCHARGE: 
DIAGNOSIS: 
PROCEDURE: 
HISTORY:  
CLINICAL EXAMINATION: PR, BP, SPO2,  RS,  CVS, P/A,CNS 
BASIC INVESTIGATIONS: 
a) Complete Blood Count 
b) Blood grouping & typing, 
c) BT, CT 
d) Urine routine 
e) Blood urea, RBS, Serum Creatinine, Serum electrolytes 
f) CXR-PA view 
g) ECG, ECHO 
h) USG abdomen 
ANAESTHETIC TECHNIQUE:  
Ultrasound guided interscalene brachial plexus block 
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EVALUATION OF PR, BP, SPO2 TILL END OF THE PROCEDURE 
CONTINUOUS ECG MONITORING WAS CARRIED OUT 
THROUGHOUT THE PROCEDURE 
MONITORING OF VITALS EVERY 15MIN : (ANXIOLYTICS, 
SEDATIVES, ANTIEMETICS, AND OTHERS TO BE MENTIONED) 
VITALS 
PRE
OP 
5 MIN 
15 
MIN 
30 
MIN 
45 
MIN 
1HR 
1HR 
15 
MIN 
1HR
30 
MIN 
PULSE         
B.P         
SPO2         
SIDE 
EFFECTS 
        
REMARKS         
 
DURATION OF SURGERY: 
ANAESTHESIA RECOVERY TIME: 
IMMEDIATE POSTBLOCK PAIN INTENSITY (NRS): 
0   MEANING NO PAIN 
10 MEANING EXCRUCIATING PAIN 
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POSTOP PERIOD: MONITORING OF VITALS 
 
PARAMETERS 
30 
MIN 
1 
HR 
2 
HR 
4 
HRS 
6 
HRS 
8 
HRS 
10 
HRS 
12 
HRS 
24 
HRS 
PULSE          
B.P          
SPO2          
VAS SCORE          
SIDE 
EFFECTS 
         
REMARKS          
 
(SIDE EFFECTS includes pain, hypotension, nausea, vomiting, headache, dyspnea) 
Parameters 
Conventional 
Group 
Extrafascial 
Group 
Respiratory-related outcomes   
Pre-procedure   
Forced vital capacity (L)   
Forced expiratory volume in 1 s (L)   
Peak expiratory ﬂow (L s−1)   
Post-procedure   
Forced vital capacity (L)   
Forced expiratory volume in 1 s (L)   
Peak expiratory ﬂow (L s−1)   
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Percentage reduction   
Forced vital capacity (%)   
Forced expiratory volume in 1 s (%)   
Peak expiratory ﬂow (%)   
Block-related outcomes   
Onset time of sensory block (min)   
Onset time of motor block (min)   
Duration of sensory block (min)   
Duration of motor block (min)   
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QUESTIONAIRRES USED IN THE STUDY 
 
 
1) H/O Any Known allergy to Local Anaesthetics/ any drugs 
2) H/O Previous Neurological deficit 
3) H/O Any Bleeding diathesis 
4) Any infection/Local sepsis at block site 
5) H/O Any Anti-Psychiatric drugs 
6) H/O Any systemic illness-Hypertension Diabetes Mellitus, Bronchial Asthma, 
Seizuredisorder, Pulmonary Tuberculosis.  
7) H/O of smoking ,COPD, Exertional dyspnoea, decreased urine output 
( Complaints related to CVS, RS, RENAL system) 
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MASTER SHEET 
CONVENTIONAL GROUP 
S.NO. NAME 
    Pre-procedure Post-procedure 
Percentage 
reduction 
Block related outcomes 
Hemidia 
phragmatic 
paresis AGE SEX WEIGHT ASA FVC FEV1 PEF FVC FEV1 PEF FVC FEV1 PEF 
Onset 
of 
sensory 
Onset 
of 
motor 
Post op 
Analgesia 
1 KANAGARAJ 28 M 22 I 5 3 7 2.7 2.6 6 28 28 24 12 8 1134 present 
2 GANESHAN 29 M 21 I 4.5 3.2 6.5 3.7 2.7 7 27 27 23 10 9 1135 present 
3 KANNAN 27 M 24 I 6 3.9 7 2.6 3 6.2 26 26 22 14 7 1133 present 
4 SURYA 28 M 23 II 4.5 3.4 8 2.9 2.2 6.3 25 25 21 11 10 1136 absent 
5 KAVISELVAN 32 M 24 I 4.5 3 9 3.8 2 6.3 24 26 22 13 9 1132 present 
6 MANIKANDAN 32 M 21 II 3.5 3.5 6.7 2.9 3 5.9 23 27 23 13 8 1134 present 
7 SABARI 33 M 60 I 5 3.6 6.1 3.6 2.2 5.7 29 28 24 11 7 1133 present 
8 AMMASI 34 M 70 II 4.2 3.3 7.4 3.7 2.1 6 30 30 25 14 10 1135 present 
9 SIVAKUMAR 35 M 80 II 4.5 3 6.9 2.9 2.2 5.2 31 31 26 15 16 1132 present 
10 AKILA 34 F 87 II 4.6 4 7.4 2.8 2.4 5.3 32 32 27 13 9 1131 present 
11 AMBIKA 36 F 67 I 4.8 3.5 7.9 3.3 2.6 5.5 33 33 28 11 10 1136 present 
12 VERAYEE 37 F 65 II 3.9 3.9 8.2 3.4 2.7 5.6 34 34 26 10 9 1130 present 
13 SARASWATHI 34 F 54 I 4 3.2 8.8 3.5 2.1 6 35 32 22 10 11 1129 present 
14 MALLIKA 36 F 56 II 4.2 3.4 9 3.6 2.8 6.6 36 34 23 15 6 1129 present 
15 LAKSHMI 42 F 57 I 4.7 3.3 7.8 3.1 2.9 7 29 29 21 14 6 1130 present 
16 CHELLAMMAL 43 F 75 I 3.9 3.5 6.7 3.2 2 7.2 28 28 23 11 7 1133 present 
17 MARISHWARI 43 F 68 I 3.5 3.6 6.6 3.8 2.1 5.9 27 27 22 11 6 1130 present 
18 UMARANI 43 F 97 I 4.6 3.2 6.9 3.7 2.2 6.4 26 26 24 10 7 1132 present 
19 SANGEETHA 44 F 57 II 4.8 3.5 7.4 3.9 3 6 30 25 25 14 6 1135 present 
20 MEENAMBAL 46 F 59 II 4 3.4 8 4.1 2.1 6.9 31 24 23 15 6 1133 present 
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EXTRAFASCIAL GROUP 
S. 
NO. 
NAME 
    Pre-procedure Post-procedure 
Percentage 
reduction 
Block related outcomes 
Hemidia 
phragmatic 
paresis AGE SEX WEIGHT ASA FVC FEV1 PEF FVC FEV1 PEF FVC FEV1 PEF 
Onset 
of 
sensory 
Onset 
of 
motor 
Post op 
Analgesia 
1 MURUGESHWARI 24 F 23 I 4.6 3.7 8.7 3.8 3.1 7.6 17 16 8 19 17 980 absent 
2 SELVI 25 F 22 I 4.4 3.6 8.3 3.9 3.2 7.7 16 15 7 18 16 1100 absent 
3 JAYANTHI 27 F 23 II 4 3.5 8.8 3.1 3.3 7.8 18 16 9 20 15 970 absent 
4 SUDHA 28 F 23 I 4.9 3.4 7.9 4 3.4 7.9 19 17 6 21 18 980 absent 
5 RAKKU 32 F 59 II 4.8 3.3 7.8 4.1 3.5 8 20 18 9 22 19 990 absent 
6 VIJAYA 35 F 56 II 4.6 4 7.7 4.2 3.6 7.5 16 19 10 23 18 990 absent 
7 SIVAMANI 36 M 65 I 4.4 3.9 8.1 4.3 3.7 7.4 15 11 11 19 17 1010 absent 
8 MURUGAN 39 M 66 I 4 3.1 8.2 4.4 3.8 7.3 14 12 9 18 16 1100 present 
9 MALAISAMY 41 M 62 II 3.8 3.2 8.3 3.9 3 7.2 13 13 8 17 15 970 absent 
10 NAGARAJ 42 M 58 I 3.9 3.3 8.4 3.9 2.9 7.1 12 14 7 16 14 990 absent 
11 SUBRAMANI 43 M 70 II 4.9 3.5 8.5 3.8 2.8 6.9 19 15 6 20 16 998 absent 
12 RAJAMMAL 45 F 55 II 4 3.4 7.9 3.7 2.7 6.8 18 16 11 21 17 980 present 
13 ANJALI 47 F 58 II 4 3.9 7.8 3.7 2.6 7.7 17 17 10 22 18 1100 absent 
14 NAGALAKSHMI 48 F 40 II 3.8 4 8.5 3.6 2.6 7.8 16 13 9 23 19 1010 absent 
15 
SHEIK 
MOHAMMED 
46 M 70 I 4.4 4 8.6 4 2.5 7.6 15 15 8 19 20 1000 absent 
16 SANKAR 45 M 66 I 5 3.7 8.5 4.1 2.4 7.5 14 17 7 18 18 970 present 
17 BALA MURALI 43 M 86 I 4.2 3.3 8.9 4.2 2.3 7.9 13 18 6 17 17 980 absent 
18 VEERAKUMAR 45 M 69 I 4.3 3.2 8.3 4.2 2.2 7.4 12 19 11 15 18 990 absent 
19 YUVARAJ 46 M 70 II 4.4 4 8.3 3.9 2.1 7.1 16 18 11 18 17 1000 absent 
20 MARTIN 46 M 76 II 4.2 3.7 8.4 4 3 7.3 17 16 10 19 19 900 absent 
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